NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Pelvic Proprioceptive Neuromuscular Facilitation (PNF) Exercises in Multiple Sclerosis Patients

NCT06198972

CompletedNA

Sponsor: Kahramanmaras Sutcu Imam University

Conditions: Multiple Sclerosis

Interventions: Pelvic Pnf exercises, Strength exercises

Countries: Turkey (Türkiye)

Multiple Sclerosis (MS) is an autoimmune, demyelinating disease that progresses with motor and sensory loss of the central nervous system and causes disability at different levels. Although signs and symptoms vary depending on the location of the lesion, findings such as loss of muscle strength, spasticity, sensory disorders and fatigue cause decreases in walking function in the majority of patients. Loss of muscle strength and fatigue cause loss of mobility, causing individuals with MS to be less physically active than healthy adults in the same age group. As a result, approximately 40% of individuals with MS have walking problems and approximately 70% of them experience a decrease in daily living activities. Literature studies frequently include strengthening exercises for lower extremity muscles in MS patients. However, the results of pelvic pattern exercises, which are the key to lower extremity movements, are not specified. In this study, which is planned in the light of this information, the findings obtained from pelvic PNF exercises will serve to fill this gap in the literature.

Eligibility overview

Sex: ALL

Age: 18 Years to 50 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

Consent for the study was obtained;

* Between 18-50 years of age,
* Extended Disability Status Scale (EDSS) score of 4 and below,
* Not in the habit of exercising regularly
* Can walk on the treadmill,
* Not pregnant,
* Not receiving corticosteroid treatment in the last 1 month,
* Fampridine etc. in the last month. not taking medication,
* Patients who have not received Botox treatment in the last 6 months will be included.

Exclusion Criteria:

* Individuals who cannot tolerate the treatment programs and cannot ensure their continuity (2 weeks in a row) will be excluded from the study.

Locations (1)

Gaziantep, Turkey (Türkiye)